–by Marie Jung The popularization of science may not be new, but there seems to be a growing trend towards improving scientific literacy among the general public. The revamping of Carl Sagan’s beloved Cosmos series really indicates the renewed interest in the natural world. The most prominent changes, however, take Read more
May 9 SDCRN program slides. “How Mobile Tech is Transforming Clinical Research.”
Here are the slides for the San Diego Clinical Research Network + San Diego Regulatory Affairs Network program on May 9. Clinical Trials in the Future. How Mobile Technologies and Telemedicine are Transforming Clinical Research. UNLOCKING ACCESS: HOW MOBILE TECHNOLOGY ACCELERATES DISCOVERY Kevin Bruhn, Ph.D., VP, Strategic Development, Science 37 The Read more
May 9 SDCRN program blog. “How mobile tech is transforming clinical research”
May 9, 2016. SDCRN+SDRAN joint program The Future of Clinical Trials. How Mobile Technologies and Telemedicine are Transforming Clinical Research By Roberta Alexander, Ph.D. San Diego Clinical Research Network (SDCRN) and San Diego Regulatory Affairs Network (SDRAN) came together to discuss ways to utilize telemedicine and mobile technologies in clinical Read more
Industry calls for more guidance from FDA on new clinical trials technology
The initiation of a new era of mobile health technology has erupted into industry calling on the US Food and Drug Administration (FDA) to offer more guidance on how best to use new technology, like Fitbits and mobile apps, in clinical trials, and to find ways that don’t restrict the development of novel tech products. (raps.org)
Technology and the Fragility of Life
By Rubi Linares-Orozco During my senior year as an undergraduate, I lost one of the most influential people in my life, my Aunt Gladis. What was meant to be a routine surgery ended up being her last moments of breath. My aunt died from kidney failure post-surgery. I think this early Read more
Advancing Drug Development with Digital Health: 4 Key Ways to Integrate Patient-Generated Data into Trials
Life sciences and mobile apps
Decline in economic returns from new drugs raises questions about sustaining innovations
…We found that the average present values of lifetime net economic returns were positive and reached a peak with the 1995–99 and 2000–04 new drug cohorts. However, returns have fallen sharply since then, with those for the 2005–09 cohort being very slightly negative and, on average, failing to recoup research and development and other costs.
Mobile health: the power of wearables, sensors, and apps to transform clinical trials
Fitbit’s heart rate monitoring accuracy questioned in class action suit
Fitbit is facing yet another class action suit, this time over its heart rate monitoring, which plaintiffs claim is inaccurate to a dangerous degree.